|
Market Closed -
Nasdaq
23:00:00 28/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 586.48 USD | -0.80% |
|
+4.08% | +20.37% |
| 12:21am | United Therapeutics Insider Sold Shares Worth $5,583,418, According to a Recent SEC Filing | MT |
| 05:49pm | United Therapeutics Wins FDA Clearance for Treprostinil-Iloprost Phase 1 Trial | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.80% | +4.08% | +20.79% | +12.00% | +20.37% | +41.20% | +165.82% | +205.19% | +396.43% | 25.36B | |
| +0.50% | +1.38% | +8.74% | +5.54% | +19.88% | +57.09% | +127.73% | +408.51% | +1,628.57% | 1,143B | |
| +0.86% | +5.14% | -0.33% | +1.62% | +30.97% | +45.00% | +84.34% | +66.44% | +135.01% | 647B | |
| -0.14% | +0.42% | +7.40% | +8.66% | +25.17% | +25.69% | +101.56% | +160.77% | +396.51% | 506B | |
| -0.05% | +2.28% | +10.69% | +10.75% | +21.51% | +49.14% | +67.74% | +12.48% | +73.17% | 384B | |
| -0.63% | -5.97% | -5.22% | +6.91% | +33.89% | +61.93% | +37.25% | +62.83% | +139.51% | 350B | |
| +0.34% | +2.15% | +7.86% | +0.54% | +17.90% | +25.26% | +54.27% | +69.98% | +80.98% | 293B | |
| -0.45% | +1.16% | +1.69% | -0.96% | -7.44% | +1.74% | +26.08% | +41.92% | +176.61% | 265B | |
| +0.87% | +3.08% | +8.06% | +14.94% | +38.04% | +54.69% | +71.67% | +118.10% | +211.22% | 242B | |
| +0.08% | +3.67% | +4.59% | +18.52% | +29.71% | +35.05% | +104.71% | +136.41% | +115.48% | 197B | |
| -1.73% | -2.37% | +0.79% | -21.90% | -21.60% | -25.00% | -61.38% | -25.02% | +82.60% | 171B | |
| -1.17% | -1.34% | +2.54% | +16.63% | +18.27% | +20.20% | -3.60% | -31.80% | -7.77% | 170B | |
| +1.66% | +0.99% | +0.38% | +8.01% | +16.84% | +25.40% | +48.19% | +191.04% | +582.77% | 132B | |
| -1.59% | -0.90% | -5.18% | -4.76% | +12.29% | +41.45% | +18.19% | +6.02% | +18.76% | 126B | |
| -0.67% | -5.41% | +12.18% | +7.99% | +17.10% | +19.39% | +113.73% | +368.52% | +673.96% | 113B | |
| -4.78% | -1.98% | -1.05% | -6.60% | +0.38% | +11.68% | +27.79% | +1.62% | -10.14% | 103B | |
| +0.48% | +2.62% | +5.18% | -2.93% | -8.72% | -14.32% | -7.28% | -11.96% | +9.66% | 100B | |
| -0.35% | +0.94% | +8.11% | +16.99% | +5.36% | +24.26% | +4.58% | +30.08% | +128.56% | 81.49B | |
| +2.98% | -12.87% | +8.56% | +283.77% | +626.23% | +744.83% | +189.14% | -38.44% | - | 83.03B | |
| -1.11% | +2.86% | -0.03% | -3.42% | -19.76% | -2.55% | +48.03% | +53.81% | +470.17% | 69.7B | |
| Average | +0.01% | +0.18% | +4.79% | +18.62% | +43.82% | +62.11% | +60.93% | +91.32% | +279.06% | 260.07B | |
| Weighted average by Cap. | +0.45% | +0.36% | +4.82% | +9.61% | +28.80% | +48.12% | +74.58% | +148.05% | +506.32% |
- Stock Market
- Stocks
- UTHR Stock
- Sector United Therapeutics Corporation
Select your edition
All financial news and data tailored to specific country editions
